News Focus
News Focus
Followers 177
Posts 16262
Boards Moderated 1
Alias Born 01/26/2016

Re: H2theIzzo post# 135745

Friday, 09/22/2017 2:00:11 PM

Friday, September 22, 2017 2:00:11 PM

Post# of 824158
H2theIzzo,

I am just guessing but I expect there will be some news even if it is not top line results. This last raise won't last long and price moving news is definately needed. Linda will be talking about how to succeed in the midst of a competitive environment. A blinded review of what is currently known about the Phase 3 trial by an investigator from Kings College coupled with an explanation why there may be synergies with other treatments at crossover might go a long way to explain how time can play a critical or even deciding factor with regard to success or failure of a trial. Linda could then also share the impact of reimbursement considerations and other aspects of product development that have not been well explained or understood by many investors. Beyond this I think the attacks that NWBO has suffered will be mentioned by Linda as part of what should be expected by a small bio that intends to survive under the direction of original leadership and how NWBO has been able to do this. Based on various clues we have seen mentioned on this board I would expect a mention of the investigation and hints of the impact it might be having to date during this part of her presentation. I also expect a progress report of sorts will highlight many or most of the 10 things flipper44 has mentioned in his points for consideration. Best wishes.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News